Medical News

RSS

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma.

6 Nov 2009

LifePoint Hospitals reports financial results for the third quarter ended September 30, 2009

LifePoint Hospitals, Inc. today announced results for the third quarter and nine months ended September 30, 2009.

6 Nov 2009

Third-quarter 2009 financial results announced by Inhibitex

Inhibitex, Inc., today announced its financial results for the third quarter ended September 30, 2009. The Company held cash, cash equivalents and short-term investments of $21.1 million at September 30, 2009, as compared to $33.1 million at December 31, 2008.

6 Nov 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 first quarter, ended September 30, 2009.

6 Nov 2009

First Edition: October 6, 2009

Today's headlines highlight activity on different fronts -- with House Democrats scrambling to hold together fragile support for tomorrow's health bill vote while Republican lawmakers and other health reform opponents intensify their attack.

6 Nov 2009

Neurogen announces financial results for the third quarter of 2009

Neurogen Corporation, a drug development company historically focused on drugs for psychiatric and neurological disorders, today announced financial and operating results for the quarter ended September 30, 2009.

6 Nov 2009

UTSA releases its newest research numbers

The University of Texas at San Antonio (UTSA) released its newest research numbers today, reporting a 34% increase to $46,521,487 in total research spending for the Sept. 1, 2008 – Aug. 31, 2009 fiscal year (FY 09) over the previous fiscal year, when research spending totaled $34,601,444. The statistic is up 97% from just five years ago, when UTSA’s total research expenditures were $23,605,844.

6 Nov 2009

One in three asthma patients are hospitalized, reveals new national survey

In the past year, an estimated more than one million patients were hospitalized and nearly three million visited emergency rooms in the United States as a result of asthma, according to a new comprehensive national survey.

6 Nov 2009

Women may not have enough energy to support both hard workouts and getting pregnant: Study

Are you a female athlete - or just someone who likes challenging workouts -- who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.

6 Nov 2009

New book available online addresses health care disparities

Lippincott Williams & Wilkins is proud to announce publication of LGBTQ Cultures: What Health Care Professionals Need to Know About Sexual and Gender Diversity, written by Michele J. Eliason, PhD, Suzanne L Dibble, DNSc, RN, Jeanne DeJoseph, CNM, PhD, and Peggy Chinn, RN, PhD.

6 Nov 2009

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

The first public data on Ossulin™ a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA. Ossulin™ is being developed by Puredel Limited, a joint-venture between the European pharmaceutical specialty company CM&D Pharma Limited and Natreon Inc., New Brunswick, NJ., developers of the proprietary delivery platform.

6 Nov 2009

Cord Blood America answers shareholder questions about its new laboratory in Las Vegas

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed shareholder questions about its new laboratory in Las Vegas, and its recently refiled S1 with the SEC, in an interview of Matthew Schissler, founder and CEO, by analyst Francis Gaskins.

6 Nov 2009

"No Drugs Down the Drain" outreach campaign in Sacramento

California American Water has designated the week of November 9, 2009 as "No Drugs Down the Drain" week for its Sacramento service area as part of a national campaign sponsored by public and private agencies alike toward the common mission of reducing pharmaceutical pollution in our source water supplies.

6 Nov 2009

People pay more for products that carry detailed nutritional information than for light items

People would be willing to pay more for products that carry detailed nutritional information than for the so-called light items. Thus it has been confirmed by researchers from the University of Santiago de Compostela (USC) and the Centre for Agro-Food Research and Technology of Aragón (CITA) in a new study on the nutritional labelling of breakfast biscuits.

6 Nov 2009

"Doctor's Orders" to explore trends in health and medicine

The partnership between ABC News and MedPage Today entered a new phase with the November 1 premiere of "Doctor's Orders," a featured series on Good Morning America Weekend.

6 Nov 2009

Health researchers speak about PTSD in light of Remembrance Day

They've seen horrors, experienced constant threats and survived traumatic events. Canada's military personnel often come back home with memories they'd rather forget. It's not scientifically understood why some soldiers develop post-traumatic stress disorder (PTSD) while others don't. However, many veterans simply don't ask for psychological help.

6 Nov 2009

Research reveals new biological function of polycystins in regulating pressure sensing

What is the role of proteins called polycystins in patients with polycystic kidney disease? A team of researchers from CNRS and INSERM, led by Eric Honoré from the Institut de Pharmacologie Moléculaire et Cellulaire (IPMC, Université de Nice Sophia Antipolis/CNRS) has elucidated the molecular and cellular mechanisms linked to polycystin malfunctions that cause this common hereditary disease.

6 Nov 2009

CREW urge HHS to investigate CDC's approval to distribute H1NI vaccine to Wall Street firms

Today, Citizens for Responsibility and Ethics in Washington (CREW) asked Health and Human Service (HHS) Secretary Kathleen Sebelius to investigate why the Center for Disease Control (CDC) approved the distribution of the H1NI vaccine to Wall Street firms at a time when the vaccine is unavailable to most Americans.

6 Nov 2009

Journal of Public Health Management presents new ideas for building better public health workforce

A recent special supplement to the Journal of Public Health Management calls attention to the country's pressing need for a larger and fully capable public health workforce. The supplement, written by the leading academic voices in public health and published by Lippincott Williams & Wilkins (LWW), also sheds light on the challenges the U.S. faces in adequately meeting public health needs.

6 Nov 2009

Cellumen's Rat Hepatocyte Early Safety Assessment Panel increases predictivity for human DILI

Cellumen, Inc., a discovery and early safety assessment company, today announced that its in vitro Rat Hepatocyte Early Safety Assessment Panel provides increased predictivity for human drug induced liver injury (DILI) equivalent to that of a recently published panel comprised of human hepatocytes. The implications of this study have a significant impact on cost and throughput for in vitro human DILI predictive solutions.

6 Nov 2009

Medical News

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

LifePoint Hospitals reports financial results for the third quarter ended September 30, 2009

Third-quarter 2009 financial results announced by Inhibitex

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

First Edition: October 6, 2009

Neurogen announces financial results for the third quarter of 2009

UTSA releases its newest research numbers

One in three asthma patients are hospitalized, reveals new national survey

Women may not have enough energy to support both hard workouts and getting pregnant: Study

New book available online addresses health care disparities

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

Cord Blood America answers shareholder questions about its new laboratory in Las Vegas

"No Drugs Down the Drain" outreach campaign in Sacramento

People pay more for products that carry detailed nutritional information than for light items

"Doctor's Orders" to explore trends in health and medicine

Health researchers speak about PTSD in light of Remembrance Day

Research reveals new biological function of polycystins in regulating pressure sensing

CREW urge HHS to investigate CDC's approval to distribute H1NI vaccine to Wall Street firms

Journal of Public Health Management presents new ideas for building better public health workforce

Cellumen's Rat Hepatocyte Early Safety Assessment Panel increases predictivity for human DILI

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News